Prediabetes, intervening diabetes and subsequent risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study
Hu J, Fang M, Pike JR, et al.
Diabetologia. Pub. online 24 May 2023.
Leggi
MOTORE SANITÀ – Accesso regionale alle terapie innovative in Piemonte, il punto sul diabete | 29 maggio 2023
Leggi
Comparative effects of glucose-lowering medications on kidney outcomes in type 2 diabetes: the GRADE randomized clinical trial
Wexler DJ, de Boer IH, Ghosh A, et al.
JAMA Intern Med. 2023;e231487.
Leggi
The bidirectional relationship between NAFLD and type 2 diabetes: a prospective population-based cohort study
Wang M, Zhao Y, He Y et, al.
NMCD. Pub. online 16 May 2023.
Leggi
MiniMed 780G advanced hybrid closed loop system outcomes according to pubertal status – awesome study group real-life experience
Rachmiel M, Lebenthal Y, Mazor-Aronovitch K, et al.
Diabetes Technol Ther. Pub. online 23 May 2023.
Leggi
Kidney protection with canagliflozin: a combined analysis of the randomized CANVAS program and CREDENCE trials
Sridhar VS, Neuen BL, Fletcher RA, et al.
Diabetes Obes Metab. Pub. online 15 May 2023.
Leggi
Summer School AMD 2023 – Scuola di alta formazione in metodologia clinica e della ricerca | Roma, 3-4-5 luglio 2023
Leggi
Metodologie di screening e percorso diagnostico per lo scompenso cardiaco nelle persone con diabete. La Consensus ADA
Leggi
Diabetes (type 1 and type 2) in children and young people: diagnosis and management
NICE. Update, Published 11 May 2023
Leggi